{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:08:22Z","timestamp":1793678902703,"version":"4.5.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ama221340h9901"],"award-info":[{"award-number":["24ama221340h9901"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11315"],"award-info":[{"award-number":["24K11315"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25141-x","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:15:10Z","timestamp":1763723710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lung tissue T cells are activated in chronic obstructive pulmonary disease with non-small cell lung cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Mari","family":"Tone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Isono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Iwahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"2","key":"25141_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1183\/09031936.00144208","volume":"34","author":"RP Young","year":"2009","unstructured":"Young, R. P. et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir J. 34 (2), 380\u2013386 (2009).","journal-title":"Eur. Respir J."},{"issue":"6","key":"25141_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/thoraxjnl-2019-213732","volume":"75","author":"HY Park","year":"2020","unstructured":"Park, H. Y. et al. Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study. Thorax 75 (6), 506\u2013509 (2020).","journal-title":"Thorax"},{"issue":"7","key":"25141_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/thx.2004.037135","volume":"60","author":"S Wasswa-Kintu","year":"2005","unstructured":"Wasswa-Kintu, S., Gan, W. Q., Man, S. F., Pare, P. D. & Sin, D. D. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60 (7), 570\u2013575 (2005).","journal-title":"Thorax"},{"issue":"5","key":"25141_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/JTO.0000000000000144","volume":"9","author":"LA Hohberger","year":"2014","unstructured":"Hohberger, L. A. et al. Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. J. Thorac. Oncol. 9 (5), 639\u2013645 (2014).","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"25141_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1164\/rccm.201505-0894OC","volume":"192","author":"RP Young","year":"2015","unstructured":"Young, R. P. et al. Airflow limitation and histology shift in the National lung screening Trial. The NLST-ACRIN cohort substudy. Am. J. Respir Crit. Care Med. 192 (9), 1060\u20131067 (2015).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"3","key":"25141_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1513\/AnnalsATS.201609-741OC","volume":"14","author":"RJ Hopkins","year":"2017","unstructured":"Hopkins, R. J. et al. Reduced expiratory flow rate among heavy smokers increases lung cancer Risk. Results from the National lung screening Trial-American college of radiology imaging network cohort. Ann. Am. Thorac. Soc. 14 (3), 392\u2013402 (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"3","key":"25141_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1164\/rccm.201704-0795OC","volume":"197","author":"NM Mark","year":"2018","unstructured":"Mark, N. M. et al. Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in Non-Small cell lung cancer. Am. J. Respir Crit. Care Med. 197 (3), 325\u2013336 (2018).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"7","key":"25141_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1164\/rccm.201706-1110OC","volume":"198","author":"J Biton","year":"2018","unstructured":"Biton, J. et al. Impaired Tumor-Infiltrating T cells in patients with chronic obstructive pulmonary disease impact lung cancer response to PD-1 Blockade. Am. J. Respir Crit. Care Med. 198 (7), 928\u2013940 (2018).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"9","key":"25141_CR9","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1002\/ijc.32235","volume":"145","author":"SH Shin","year":"2019","unstructured":"Shin, S. H. et al. Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease. Int. J. Cancer. 145 (9), 2433\u20132439 (2019).","journal-title":"Int. J. Cancer"},{"issue":"4","key":"25141_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo, J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir Crit. Care Med. 187 (4), 347\u2013365 (2013).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"25141_CR11","doi-asserted-by":"publisher","first-page":"15076","DOI":"10.1038\/nrdp.2015.76","volume":"1","author":"PJ Barnes","year":"2015","unstructured":"Barnes, P. J. et al. Chronic obstructive pulmonary disease. Nat. Rev. Dis. Primers. 1, 15076 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"25141_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri2254","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes, P. J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8 (3), 183\u2013192 (2008).","journal-title":"Nat. Rev. Immunol."},{"issue":"26","key":"25141_CR13","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1056\/NEJMoa032158","volume":"350","author":"JC Hogg","year":"2004","unstructured":"Hogg, J. C. et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl. J. Med. 350 (26), 2645\u20132653 (2004).","journal-title":"N Engl. J. Med."},{"issue":"3 Pt 1","key":"25141_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1164\/ajrccm.157.3.9709027","volume":"157","author":"M Saetta","year":"1998","unstructured":"Saetta, M. et al. CD8\u2009+\u2009T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir Crit. Care Med. 157 (3 Pt 1), 822\u2013826 (1998).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"25141_CR15","unstructured":"Villase\u00f1or-Altamirano, A. B. et al. Activation of CD8\u2009+\u2009T cells in COPD lung. Am. J. Respir Crit. Care Med. (2023)."},{"issue":"5","key":"25141_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1164\/rccm.200410-1332OC","volume":"172","author":"AK Sullivan","year":"2005","unstructured":"Sullivan, A. K. et al. Oligoclonal CD4\u2009+\u2009T cells in the lungs of patients with severe emphysema. Am. J. Respir Crit. Care Med. 172 (5), 590\u2013596 (2005).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"9","key":"25141_CR17","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir Crit. Care Med. 205 (9), e18\u2013e47 (2022).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"15","key":"25141_CR18","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1158\/1078-0432.CCR-18-4142","volume":"25","author":"I Datar","year":"2019","unstructured":"Datar, I. et al. Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human Non-Small cell lung cancer using spatially resolved and multiparametric Single-Cell analysis. Clin. Cancer Res. 25 (15), 4663\u20134673 (2019).","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"25141_CR19","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1182\/bloodadvances.2020003080","volume":"5","author":"M Roussel","year":"2021","unstructured":"Roussel, M. et al. Functional characterization of PD1\u2009+\u2009TIM3\u2009+\u2009tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 Blockade. Blood Adv. 5 (7), 1816\u20131829 (2021).","journal-title":"Blood Adv."},{"issue":"10","key":"25141_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2326-6066.CIR-22-0362","volume":"10","author":"R Reschke","year":"2022","unstructured":"Reschke, R. et al. Checkpoint Blockade-Induced dermatitis and colitis are dominated by Tissue-Resident memory T cells and Th1\/Tc1 cytokines. Cancer Immunol. Res. 10 (10), 1167\u20131174 (2022).","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"25141_CR21","doi-asserted-by":"publisher","first-page":"2197358","DOI":"10.1080\/2162402X.2023.2197358","volume":"12","author":"R Reschke","year":"2023","unstructured":"Reschke, R. & Gajewski, T. F. Tissue-resident memory T cells in immune-related adverse events: friend or foe? Oncoimmunology 12 (1), 2197358 (2023).","journal-title":"Oncoimmunology"},{"issue":"2","key":"25141_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.chest.2021.02.032","volume":"160","author":"WT Atchley","year":"2021","unstructured":"Atchley, W. T. et al. Immune checkpoint Inhibitor-Related pneumonitis in lung cancer: Real-World Incidence, risk Factors, and management practices across six health care centers in North Carolina. Chest 160 (2), 731\u2013742 (2021).","journal-title":"Chest"},{"issue":"1","key":"25141_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12890-022-02190-w","volume":"22","author":"Z Zeng","year":"2022","unstructured":"Zeng, Z. et al. Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease. BMC Pulm Med. 22 (1), 458 (2022).","journal-title":"BMC Pulm Med."},{"issue":"6502","key":"25141_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/372190a0","volume":"372","author":"KL Cepek","year":"1994","unstructured":"Cepek, K. L. et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372 (6502), 190\u2013193 (1994).","journal-title":"Nature"},{"key":"25141_CR25","doi-asserted-by":"publisher","first-page":"1205984","DOI":"10.3389\/fimmu.2023.1205984","volume":"14","author":"I Damei","year":"2023","unstructured":"Damei, I., Trickovic, T., Mami-Chouaib, F. & Corgnac, S. Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy. Front. Immunol. 14, 1205984 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"25141_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40425-018-0399-6","volume":"6","author":"F Mami-Chouaib","year":"2018","unstructured":"Mami-Chouaib, F. et al. Resident memory T cells, critical components in tumor immunology. J. Immunother Cancer. 6 (1), 87 (2018).","journal-title":"J. Immunother Cancer"},{"issue":"3","key":"25141_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1084\/jem.20061524","volume":"204","author":"A Le Floc\u2019h","year":"2007","unstructured":"Le Floc\u2019h, A. et al. Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J. Exp. Med. 204 (3), 559\u2013570 (2007).","journal-title":"J. Exp. Med."},{"issue":"8","key":"25141_CR28","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni.3775","volume":"18","author":"AP Ganesan","year":"2017","unstructured":"Ganesan, A. P. et al. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18 (8), 940\u2013950 (2017).","journal-title":"Nat. Immunol."},{"issue":"7","key":"25141_CR29","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.xcrm.2020.100127","volume":"1","author":"S Corgnac","year":"2020","unstructured":"Corgnac, S. et al. CD103. Cell. Rep. Med. 1 (7), 100127 (2020).","journal-title":"Cell. Rep. Med."},{"key":"25141_CR30","doi-asserted-by":"crossref","unstructured":"Banchereau, R. et al. Intratumoral CD103\u2009+\u2009CD8\u2009+\u2009T cells predict response to PD-L1 Blockade. J. Immunother Cancer 9(4) (2021).","DOI":"10.1136\/jitc-2020-002231"},{"issue":"1","key":"25141_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/thorax.58.1.23","volume":"58","author":"MJ Leckie","year":"2003","unstructured":"Leckie, M. J. et al. Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69\u2009+\u2009CD103+). Thorax 58 (1), 23\u201329 (2003).","journal-title":"Thorax"},{"key":"25141_CR32","doi-asserted-by":"publisher","first-page":"616309","DOI":"10.3389\/fimmu.2021.616309","volume":"12","author":"K Hirahara","year":"2021","unstructured":"Hirahara, K., Kokubo, K., Aoki, A., Kiuchi, M. & Nakayama, T. The role of CD4. Front. Immunol. 12, 616309 (2021).","journal-title":"Front. Immunol."},{"issue":"3","key":"25141_CR33","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41590-018-0298-5","volume":"20","author":"S Zundler","year":"2019","unstructured":"Zundler, S. et al. Hobit- and Blimp-1-driven CD4. Nat. Immunol. 20 (3), 288\u2013300 (2019).","journal-title":"Nat. Immunol."},{"key":"25141_CR34","doi-asserted-by":"crossref","unstructured":"Herrera-De La Mata, S. et al. Cytotoxic CD4 Med. (2023).","DOI":"10.1016\/j.medj.2023.09.003"},{"key":"25141_CR35","doi-asserted-by":"publisher","first-page":"101834","DOI":"10.1016\/j.smim.2023.101834","volume":"70","author":"KM Quinn","year":"2023","unstructured":"Quinn, K. M., Vicencio, D. M. & La Gruta, N. L. The paradox of aging: Aging-related shifts in T cell function and metabolism. Semin Immunol. 70, 101834 (2023).","journal-title":"Semin Immunol."},{"key":"25141_CR36","unstructured":"Global strategy for the. diagnosis, management, and prevention of chronic obstructive pulmonary disease. [accessed 07 Jul 2022]. Available: https:\/\/goldcopd.org\/\u00a0."},{"issue":"1","key":"25141_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/mt.2014.156","volume":"23","author":"K Iwahori","year":"2015","unstructured":"Iwahori, K. et al. Engager T cells: a new class of antigen-specific T cells that redirect bystander T cells. Mol. Ther. 23 (1), 171\u2013178 (2015).","journal-title":"Mol. Ther."},{"issue":"1","key":"25141_CR38","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1038\/s41598-019-39345-5","volume":"9","author":"K Iwahori","year":"2019","unstructured":"Iwahori, K. et al. Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment. Sci. Rep. 9 (1), 2636 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"25141_CR39","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1038\/s41598-020-61053-8","volume":"10","author":"Y Yamamoto","year":"2020","unstructured":"Yamamoto, Y. et al. Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors. Sci. Rep. 10 (1), 4064 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"25141_CR40","doi-asserted-by":"publisher","first-page":"17461","DOI":"10.1038\/s41598-022-22356-0","volume":"12","author":"K Iwahori","year":"2022","unstructured":"Iwahori, K. et al. Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients. Sci. Rep. 12 (1), 17461 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25141-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:15:12Z","timestamp":1763723712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25141-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25141"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25141-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41209"}}